FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Hyobin PremierZen Black 5000 Recall

PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card…

Hyobin LLC · Ridgewood, NJ

Risk level
Class II
Reported by FDA
May 26, 2021
Recall ID
D-0382-2021
Check your lot numberHow we source this data

Summary

Hyobin recalled PremierZen Black 5000 starting Apr 6, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0382-2021 on May 26, 2021. Reason: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil. Status: Ongoing.

Why it was recalled

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.

Product description

PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ

Lot numbers, UPCs & expiration codes

all lots

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0382-2021
Classification
Class II
Status
Ongoing
Recall initiated
Apr 6, 2021
FDA report date
May 26, 2021
Quantity
500 cards
Recall type
Voluntary: Firm initiated
Recalling firm
Hyobin LLC

Original FDA data

Every field from FDA enforcement report D-0382-2021, exactly as published.

Show all FDA fields
City
Ridgewood
State
NJ
Status
Ongoing
Country
United States
Event ID
87711
Address
455 S Pleasant Ave
Code information
all lots
Postal code
07450-5413
Report date
May 26, 2021
Product type
Drugs
Recall number
D-0382-2021
Classification
Class II
Recalling firm
Hyobin LLC
Product quantity
500 cards
Reason for recall
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ
Distribution pattern
USA Nationwide
Recall initiation date
Apr 6, 2021
Initial firm notification
Press Release
Center classification date
May 14, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0382-2021, published May 26, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls